| 2101 |
Bone Marrow Family |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
76 |
| 2102 |
Bone Marrow Family |
Allogeneic |
Langerhans Cell Sarcoma |
Hematology |
2023 |
Standard Therapy |
Poland |
66 |
| 2103 |
Bone Marrow Family |
Allogeneic |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Poland |
63 |
| 2104 |
Bone Marrow Family |
Allogeneic |
Mycosis Fungoides |
Hematology |
2023 |
Standard Therapy |
Poland |
71 |
| 2105 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
71 |
| 2106 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
68 |
| 2107 |
Bone Marrow Family |
Allogeneic |
Myelofibrosis |
Hematology |
2023 |
Standard Therapy |
Poland |
70 |
| 2108 |
Bone Marrow Family |
Allogeneic |
No Data |
Hematology |
2023 |
Standard Therapy |
Germany |
70 |
| 2109 |
Bone Marrow Family |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2023 |
Standard Therapy |
Poland |
55 |
| 2110 |
Bone Marrow Family |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
73 |
| 2111 |
Bone Marrow Family |
Allogeneic |
Secondary Chronic Myelomonocytic Leukemia To Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
62 |
| 2112 |
Bone Marrow Family |
Allogeneic |
Secondary Myelodysplastic Syndrome With Excess Of Blasts |
Hematology |
2023 |
Standard Therapy |
Poland |
15 |
| 2113 |
Bone Marrow Family |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
71 |
| 2114 |
Bone Marrow Family |
Allogeneic |
T-Cell Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
5 |
| 2115 |
Bone Marrow |
Allogeneic |
Acute Leukemia Of Ambiguous Lineage |
Hematology |
2023 |
Standard Therapy |
Poland |
1 |
| 2116 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
11 |
| 2117 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
5 |
| 2118 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
16 |
| 2119 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
28 |
| 2120 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
14 |
| 2121 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
1 |
| 2122 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
25 |
| 2123 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
7 |
| 2124 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
4 |
| 2125 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
8 months |
| 2126 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
12 |
| 2127 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
63 |
| 2128 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
5 |
| 2129 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
12 |
| 2130 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
3 |
| 2131 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
49 |
| 2132 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
14 |
| 2133 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
47 |
| 2134 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
11 |
| 2135 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
13 |
| 2136 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
17 |
| 2137 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
32 |
| 2138 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
43 |
| 2139 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
12 |
| 2140 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
59 |
| 2141 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
38 |
| 2142 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
14 |
| 2143 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
1 |
| 2144 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
75 |
| 2145 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
55 |
| 2146 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
13 |
| 2147 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
6 |
| 2148 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
17 |
| 2149 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
34 |
| 2150 |
Bone Marrow |
Allogeneic |
Adrenoleukodystrophy |
Hematology |
2023 |
Standard Therapy |
Poland |
7 |
| 2151 |
Bone Marrow |
Allogeneic |
Adrenoleukodystrophy (Ald) – Siemerling-Creutzfeldt Disease |
Hematology |
2023 |
Standard Therapy |
Poland |
4 |
| 2152 |
Bone Marrow |
Allogeneic |
Amegakaryocytic Thrombocytopenia |
Hematology |
2023 |
Standard Therapy |
Poland |
6 months |
| 2153 |
Bone Marrow |
Allogeneic |
Anemia Fanconi |
Hematology |
2023 |
Standard Therapy |
Poland |
6 |
| 2154 |
Bone Marrow |
Allogeneic |
Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
18 |
| 2155 |
Bone Marrow |
Allogeneic |
Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
43 |
| 2156 |
Bone Marrow |
Allogeneic |
B-Cell Precursor Acute Lymphocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
12 |
| 2157 |
Bone Marrow |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2023 |
Standard Therapy |
Poland |
12 |
| 2158 |
Bone Marrow |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
55 |
| 2159 |
Bone Marrow |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
57 |
| 2160 |
Bone Marrow |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
40 |
| 2161 |
Bone Marrow |
Allogeneic |
Chronic Myeloid Leukemia Blast Crisis |
Hematology |
2023 |
Standard Therapy |
Poland |
21 |
| 2162 |
Bone Marrow |
Allogeneic |
Clippers Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
49 |
| 2163 |
Bone Marrow |
Allogeneic |
Congenital Amegakaryocytic Thrombocytopenia (Camt) |
Hematology |
2023 |
Standard Therapy |
Poland |
6 months |
| 2164 |
Bone Marrow |
Allogeneic |
Fanconi Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
8 |
| 2165 |
Bone Marrow |
Allogeneic |
Hemophagocytic Lymphohistiocytosis (Hlh) |
Hematology |
2023 |
Standard Therapy |
Poland |
2 |
| 2166 |
Bone Marrow |
Allogeneic |
Hodgkin’s Lymphoma |
Hematology |
2023 |
Standard Therapy |
Poland |
23 |
| 2167 |
Bone Marrow |
Allogeneic |
Immunodeficiency – Xlp1 |
Hematology |
2023 |
Standard Therapy |
Poland |
10 |
| 2168 |
Bone Marrow |
Allogeneic |
Juvenile Myelomonocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
5 |
| 2169 |
Bone Marrow |
Allogeneic |
Mantle Cell Lymphoma |
Hematology |
2023 |
Standard Therapy |
Poland |
68 |
| 2170 |
Bone Marrow |
Allogeneic |
Metachromatic Leukodystrophy |
Hematology |
2023 |
Standard Therapy |
Poland |
22 |
| 2171 |
Bone Marrow |
Allogeneic |
Mitochondrial Neurogastrointestinal Encephalopathy |
Hematology |
2023 |
Standard Therapy |
Poland |
33 |
| 2172 |
Bone Marrow |
Allogeneic |
Mixed Lineage Acute Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
4 |
| 2173 |
Bone Marrow |
Allogeneic |
Monocytopenia And Mycobacterial Infection (Monomac) Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
5 |
| 2174 |
Bone Marrow |
Allogeneic |
Mucopolysaccharidosis Type I |
Hematology |
2023 |
Standard Therapy |
Poland |
2 |
| 2175 |
Bone Marrow |
Allogeneic |
Mucopolysaccharidosis Type IH (Hurler) |
Hematology |
2023 |
Standard Therapy |
Poland |
8 months |
| 2176 |
Bone Marrow |
Allogeneic |
Mucopolysaccharidosis Type Iv |
Hematology |
2023 |
Standard Therapy |
Poland |
5 |
| 2177 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
51 |
| 2178 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
11 |
| 2179 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
14 |
| 2180 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
6 |
| 2181 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
7 |
| 2182 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
19 |
| 2183 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2023 |
Standard Therapy |
Poland |
3 |
| 2184 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2023 |
Standard Therapy |
Poland |
2 |
| 2185 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2023 |
Standard Therapy |
Poland |
61 |
| 2186 |
Bone Marrow |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2023 |
Standard Therapy |
Poland |
20 |
| 2187 |
Bone Marrow |
Allogeneic |
Other Immune System |
Hematology |
2023 |
Standard Therapy |
Poland |
6 |
| 2188 |
Bone Marrow |
Allogeneic |
Other Immune System |
Hematology |
2023 |
Standard Therapy |
Poland |
6 months |
| 2189 |
Bone Marrow |
Allogeneic |
Primary Combined Severe Immunodeficiency |
Hematology |
2023 |
Standard Therapy |
Poland |
14 |
| 2190 |
Bone Marrow |
Allogeneic |
Primary Immunodeficiency |
Hematology |
2023 |
Standard Therapy |
Poland |
3 |
| 2191 |
Bone Marrow |
Allogeneic |
Primary Immunodeficiency |
Hematology |
2023 |
Standard Therapy |
Poland |
4 |
| 2192 |
Bone Marrow |
Allogeneic |
Prolymphocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
55 |
| 2193 |
Bone Marrow |
Allogeneic |
Relapsed T Cell Acute Lymphoblastic Leukemia (T-All) |
Hematology |
2023 |
Standard Therapy |
Poland |
5 |
| 2194 |
Bone Marrow |
Allogeneic |
Secondary Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
20 |
| 2195 |
Bone Marrow |
Allogeneic |
Secondary Myelofibrosis Post Polycythemia Vera |
Hematology |
2023 |
Standard Therapy |
Poland |
60 |
| 2196 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
11 |
| 2197 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
4 |
| 2198 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
31 |
| 2199 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
49 |
| 2200 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
8 |